Versant Venture Capital VI, L.P.

Average Profitability
0.91%
Insider Buys Quantity
6
Insider Buys Sum
$65.9M
Insider Sells Quantity
58
Insider Sells Sum
$62.42M

Insider Activity of Versant Venture Capital VI, L.P.

According to the SEC Form 4 filings, Versant Venture Capital VI, L.P., being in a position of

  1. 10 percent owner at Black Diamond Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 221600 shares for $1.4M,
    over all time since 2020-02-03, has bought 1789472 shares for $34M, and sold 729611 share for $18.34M.

The largest purchase of all time was on 2020-02-03 and amounted to 1789472 shares of Black Diamond Therapeutics, Inc. for $34M.

The largest sale of all time was on 2019-12-30 and amounted to 677838 shares of Akero Therapeutics, Inc. for $16.53M.

Biography of Versant Venture Capital VI, L.P.

No biography is available at this moment.

2024-10-29SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
67,905
0.1081%
$9.16$621,801-5.34%
2024-10-28SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
89,990
0.2667%
$9.66$869,2400%
2024-09-20SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
1.13M
1.8595%
$6.53$7.4M-18.21%
2024-09-13SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
9,269
0.0153%
$6.16$57,100-10.03%
2024-09-12SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
16,047
0.0263%
$6.00$96,309-7.89%
2024-09-11SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
541,897
0.833%
$6.00$3.25M+1.01%
2024-08-28SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
221,600
0.3894%
$6.32$1.4M-35.95%
2024-08-12SaleTempest Therapeutics, Inc.
TPST
10 percent owner
387,999
2.043%
$1.10$426,993+39.5%
2024-08-08SaleTempest Therapeutics, Inc.
TPST
10 percent owner
400,000
1.814%
$1.35$540,040-0.75%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
157,895
3.0944%
$19.00$3M-7.95%
2021-06-22PurchaseCentury Therapeutics, Inc.
IPSC
10 percent owner
100,000
0.6416%
$20.00$2M-41%
2020-11-30SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
10,393
0.0287%
$33.15$344,513-60.65%
2020-11-19SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
130,017
0.3608%
$33.01$4.29M-58.75%
2020-11-18SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
536
0.0015%
$33.09$17,738-58.11%
2020-11-17SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
4,194
0.0117%
$33.05$138,611-58.09%
2020-11-16SaleBlack Diamond Therapeutics, Inc.
BDTX
director
200
0.0006%
$33.01$6,603-44.27%
2020-11-13SaleBlack Diamond Therapeutics, Inc.
BDTX
director
4,500
0.0128%
$33.77$151,984-32.78%
2020-11-12SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
15,598
0.0431%
$34.15$532,642-34.91%
2020-11-11SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
12,617
0.0348%
$34.73$438,217-35.73%
2020-11-10SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
39,996
0.1101%
$33.74$1.35M-33.18%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.